Authors/Disclosures
|
Kathleen Bowler, PhD
|
No disclosure on file |
|
Kim Yen Thi Vu, LMSW
(Memorial Hermman - Texas Medical Center Mischer Neuroscience Institute)
|
No disclosure on file |
|
Furkan Yilmaz, MD
|
No disclosure on file |
|
Robert P. Rubens, MD, MBA, FAAN, FAAN
(NeuroDevMA Consulting, Inc.)
|
Dr. Rubens has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Dr. Rubens has received stock or an ownership interest from Takeda Pharmaceuticals. |
|
|
No disclosure on file |
|
Michael Gallagher, DO
(Cooper University Hospital)
|
No disclosure on file |
|
Thomas C. Wessel, MD
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Shawna M. Cutting, MD, FAAN
|
The institution of Dr. Cutting has received research support from Genentech. |
|
Huimahn A. Choi, MD
(The University of Texas Health Science Center At Houston)
|
The institution of Dr. Choi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acasti Pharma. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Thomas Roth, PhD
(Henry Ford Hospital)
|
Dr. Roth has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Takeda. Dr. Roth has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Avadel. Dr. Roth has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz. |